Literature DB >> 14588333

Mid-term clinical results of Graf stabilization for lumbar degenerative pathologies. a minimum 2-year follow-up.

T Hashimoto1, F Oha, K Shigenobu, M Kanayama, M Harada, Y Ohkoshi, H Tada, K Yamamoto, S Yamane.   

Abstract

BACKGROUND CONTEXT: Spinal fusion has some adverse effects, such as nonunion and pain at the site of grafted bone, and fusion with rigid spinal instrumentation especially may have the possibility of increasing mechanical stress on the segments adjacent to the site of fusion. The theory of the Graf system is that it will decrease adjacent disc deterioration because of maintenance of regional lordosis with flexibility and restriction of the motion of unstable segments without rigid spinal fusion.
PURPOSE: To assess the clinical and radiologic results of Graf stabilization for lumbar degenerative disorders with minimal or mild instability. STUDY
DESIGN: This is a retrospective study examining the mid-term results of Graf stabilization. PATIENT SAMPLE: In total, 59 patients underwent Graf ligamentoplasty and adequate decompression from April 1993 to September 1997. The subjects were 30 men and 29 women, and the mean age at the time of surgery was 60.6 years, ranging from 23 to 82 years. The average follow-up period was 3 years and 5 months, ranging from 2 years to 5 years and 10 months. OUTCOME MEASURES: We evaluated the surgical results using a scoring system, a visual analog scale, and radiological measurements.
METHODS: The results were assessed according to a clinical scoring system established by the Japanese Orthopaedic Association (JOA score) and ratings based on a visual analog scale. Through analysis of x-ray images, the sagittal alignment (regional lordosis) and the range of motion (ROM) of the stabilized segments were measured in all cases, and the percentage of segments slipping and posterior disc height were determined for 29 patients with degenerative spondylolisthesis.
RESULTS: Clinical scores and low back pain ratings based on a visual analog scale were significantly improved at the time of final follow-up compared with the preoperative values. Regional alignment of the operative segments was maintained in lordosis at the time of final follow-up. Preoperative ROM was significantly reduced at the time of final follow-up. There were no statistical differences in percentage of slippage or percentage of posterior disc height between the final follow-up values and the preoperative values.
CONCLUSIONS: Our clinical results indicate that the Graf system is a suitable treatment option for mild and early lumbar degenerative diseases with minimum flexion instability of less than 10 degrees.

Entities:  

Mesh:

Year:  2001        PMID: 14588333     DOI: 10.1016/s1529-9430(01)00028-6

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  4 in total

1.  Large volume inside the cage leading incomplete interbody bone fusion and residual back pain after posterior lumbar interbody fusion.

Authors:  Mikinobu Takeuchi; Mitsuhiro Kamiya; Norimitsu Wakao; Atsuhiko Hirasawa; Katsuhisa Kawanami; Koji Osuka; Masakazu Takayasu
Journal:  Neurosurg Rev       Date:  2015-02-10       Impact factor: 3.042

2.  Bone union rate with autologous iliac bone versus local bone graft in posterior lumbar interbody fusion (PLIF): a multicenter study.

Authors:  Zenya Ito; Shiro Imagama; Tokumi Kanemura; Yudo Hachiya; Yasushi Miura; Mitsuhiro Kamiya; Yasutsugu Yukawa; Yoshihito Sakai; Yoshito Katayama; Norimitsu Wakao; Yukihiro Matsuyama; Naoki Ishiguro
Journal:  Eur Spine J       Date:  2013-01-30       Impact factor: 3.134

3.  Biomechanics of posterior dynamic stabilization systems.

Authors:  D U Erbulut; I Zafarparandeh; A F Ozer; V K Goel
Journal:  Adv Orthop       Date:  2013-03-31

4.  The effects of the Mulligan Sustained Natural Apophyseal Glide (SNAG) mobilisation in the lumbar flexion range of asymptomatic subjects as measured by the Zebris CMS20 3-D motion analysis system.

Authors:  Maria Moutzouri; Evdokia Billis; Nikolaos Strimpakos; Polixeni Kottika; Jacqueline A Oldham
Journal:  BMC Musculoskelet Disord       Date:  2008-10-01       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.